Was the LIFE trial independent?
作者信息
Van Brabandt Hans
出版信息
Lancet. 2002 Oct 12;360(9340):1171; author reply 1171. doi: 10.1016/S0140-6736(02)11212-8.
Abstract
摘要
相似文献
1
Was the LIFE trial independent?
Lancet. 2002 Oct 12;360(9340):1171; author reply 1171. doi: 10.1016/S0140-6736(02)11212-8.
2
Was the LIFE trial independent?
Lancet. 2002 Oct 12;360(9340):1171; author reply 1171. doi: 10.1016/S0140-6736(02)11211-6.
3
[Hypertension plus left ventricular hypertrophy. Prognosis can now be significantly improved].
MMW Fortschr Med. 2002 Apr 4;144(14):4-5.
4
[Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
MMW Fortschr Med. 2002 Sep 19;144(38):14.
5
[Losartan in isolated systolic hypertension--convincing results of a LIFE sub-group study].
MMW Fortschr Med. 2003 Jan 16;145(1-2):50-1.
6
[Better prognosis in hypertension and left ventricular hypertrophy. LIFE Study sets new standard].
MMW Fortschr Med. 2002 May 16;144(20):60-1.
7
More on the LIFE study.
Lancet. 2003 Feb 8;361(9356):532; author reply 533-4. doi: 10.1016/S0140-6736(03)12481-6.
8
[Marketing of the LIFE trial anticipates evaluation of the drug].
Lakartidningen. 2002 Apr 25;99(17):1964.
9
More on the LIFE study.
Lancet. 2003 Feb 8;361(9356):532-3; author reply 533-4. doi: 10.1016/S0140-6736(03)12482-8.
10
[What are the consequences of the LIFE Study for general practice].
MMW Fortschr Med. 2002 Sep 19;144(38):48.
Zotero 插件